DILI
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Characteristics and Predictors of Liver Injury in Cyclin-dependent Kinase Inhibitors 4/6 (CDK4/6)-Treated Patients With Advanced Breast Cancer (NCT06367335) | University of Milano Bicocca | 2022-06-01 |
Track DILI automatically
Every clearance here is in the API, with alerts when new ones post.